The subgroup analysis on BMI revealed that overweight and obesity are associated with a reduced response to the most favorable effects of the supplementation, particularly in terms of suppressing CRP and IL-6 markers. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.